Items where Author is "Asgari, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 31.

Article

Khorasani, M. and Teimoori-Toolabi, L. and Farivar, T.N. and Asgari, M. and Abolhasani, M. and Shahrokh, H. and Afgar, A. and Kalantari, E. and Peymani, A. and Mahdian, R. (2018) Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer. Cancer Biomarkers, 22 (1). pp. 19-28.

Khorasani, M. and Teimoori-Toolabi, L. and Farivar, T.N. and Asgari, M. and Abolhasani, M. and Shahrokh, H. and Afgar, A. and Kalantari, E. and Peymani, A. and Mahdian, R. (2018) Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer. Cancer Biomarkers, 22 (1). pp. 19-28.

Malakoutian, T. and Amouzegar, A. and Asgari, M. and Shooshtarizadeh, T. (2018) C4d in lupus nephritis and correlation with clinicopathologic findings. Journal of Nephropathology, 7 (3). pp. 166-170.

Rasti, A. and Mehrazma, M. and Madjd, Z. and Abolhasani, M. and Saeednejad Zanjani, L. and Asgari, M. (2018) Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas. Scientific Reports, 8 (1).

Rasti, A. and Madjd, Z. and Abolhasani, M. and Mehrazma, M. and Janani, L. and Saeednejad Zanjani, L. and Asgari, M. (2018) Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. Clinical and Experimental Medicine, 18 (2). pp. 177-190.

Rasti, A. and Madjd, Z. and Abolhasani, M. and Mehrazma, M. and Janani, L. and Saeednejad Zanjani, L. and Asgari, M. (2018) Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. Clinical and Experimental Medicine, 18 (2). pp. 177-190.

Ostadrahimi, S. and Fayaz, S. and Parvizhamidi, M. and Abedi-Valugerdi, M. and Hassan, M. and Kadivar, M. and Teimoori-Toolabi, L. and Asgari, M. and Shahrokh, H. and Abolhasani, M. and Mahdian, R. and Fard-Esfahani, P. (2018) Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. Oncology Letters, 15 (5). pp. 8157-8164.

Ostadrahimi, S. and Fayaz, S. and Parvizhamidi, M. and Abedi-Valugerdi, M. and Hassan, M. and Kadivar, M. and Teimoori-Toolabi, L. and Asgari, M. and Shahrokh, H. and Abolhasani, M. and Mahdian, R. and Fard-Esfahani, P. (2018) Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. Oncology Letters, 15 (5). pp. 8157-8164.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Shariftabrizi, A. and Rasti, A. and Asgari, M. (2018) Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma. Cancer Biomarkers, 21 (4). pp. 821-837.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Shariftabrizi, A. and Rasti, A. and Asgari, M. (2018) Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma. Cancer Biomarkers, 21 (4). pp. 821-837.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Fodstad, O. and Andersson, Y. and Asgari, M. (2018) Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine, 12 (1). pp. 45-61.

Zanjani, L.S. and Madjd, Z. and Abolhasani, M. and Rasti, A. and Fodstad, O. and Andersson, Y. and Asgari, M. (2018) Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine, 12 (1). pp. 45-61.

Faham, M. and Torabinezhad, F. and Murry, T. and Dabirmoghaddam, P. and Abolghasemi, J. and Kamali, M. and Asgari, M. (2018) Quality of Life and Voice Changes After a Single Injection in Patients With ADSD Over Time. Journal of Voice.

Faham, M. and Torabinezhad, F. and Murry, T. and Dabirmoghaddam, P. and Abolghasemi, J. and Kamali, M. and Asgari, M. (2018) Quality of Life and Voice Changes After a Single Injection in Patients With ADSD Over Time. Journal of Voice.

Khosravi, N. and Asgari, M. and Khalessi, N. and Hoseini, R. and Khosravi, N. (2018) Serum beta-trace protein for assessment of kidney function in neonates. Iranian Journal of Kidney Diseases, 12 (1). pp. 11-13.

Khosravi, N. and Asgari, M. and Khalessi, N. and Hoseini, R. and Khosravi, N. (2018) Serum beta-trace protein for assessment of kidney function in neonates. Iranian Journal of Kidney Diseases, 12 (1). pp. 11-13.

Arefi, M. and Barzegari, N. and Asgari, M. and Soltani, S. and Farhidnia, N. and Fallah, F. (2016) Datura poisoning, clinical and laboratory findings. Report of five cases. Romanian Journal of Legal Medicine, 24 (4). pp. 308-311.

Asgari, M. and Maybodi, M.N. and Abolhasani, M. (2016) Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67. Medical Journal of the Islamic Republic of Iran, 30 (1).

Fallahabadi, Z.R. and Noori Daloii, M.R. and Mahdian, R. and Behjati, F. and Shokrgozar, M.A. and Abolhasani, M. and Asgari, M. and Shahrokh, H. (2016) Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer. Gene, 575 (2). pp. 755-760.

Jahed, M. and Ebadi, N. and Mivehchi, M. and Majidizadeh, T. and Shahshanipour, M. and Asgari, M. and Ghadakzadeh, S. and Hosseini, S.A. (2016) MGMT hypermethylation and BCL-2 overexpression associated with superficial bladder cancer and recurrence. Cancer Biomarkers, 16 (4). pp. 627-632.

Sadeghipour, A. and Hendi, A. and Asgari, M. and Sotoudeh, M. and Parvin, M. and Filip, I. and Radfar, A. and Babaheidarian, P. (2016) Validation of oxford classification of immunoglobulin a nephropathy: An Iranian experience. Iranian Journal of Kidney Diseases, 10 (1). pp. 17-21.

Malakoutian, T. and Mohammadi, R. and Asgari, M. and Amouzegar, A. (2015) Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis- case report. Iranian Journal of Parasitology, 10 (1). pp. 141-145.

Barzegar-Fallah, A. and Alimoradi, H. and Razmi, A. and Dehpour, A.R. and Asgari, M. and Shafiei, M. (2015) Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology, 767. pp. 152-159.

Aghaee-Bakhtiari, S.H. and Arefian, E. and Naderi, M. and Noorbakhsh, F. and Nodouzi, V. and Asgari, M. and Fard-Esfahani, P. and Mahdian, R. and Soleimani, M. (2015) MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. Tumor Biology, 36 (6). pp. 4203-4212.

Abolhasani, M. and Salarinejad, S. and Asgari, M. (2015) P53 and MDM2 over-expression and five-year survival of kidney cancer patients undergoing radical nephrectomy - Iranian experience. Asian Pacific Journal of Cancer Prevention, 16 (12). pp. 5043-5047.

Mohsenzadegan, M. and Shekarabi, M. and Madjd, Z. and Asgari, M. and Abolhasani, M. and Tajik, N. and Farajollahi, M.M. (2015) Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer. Biomarkers in Medicine, 9 (4). pp. 391-401.

Barzegar-Fallah, A. and Alimoradi, H. and Asadi, F. and Dehpour, A.R. and Asgari, M. and Shafiei, M. (2015) Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical and Experimental Pharmacology and Physiology, 42 (4). pp. 361-368.

Asgari, M. and Sanjari, M.A. and Mokhtarinia, H.R. and Moeini Sedeh, S. and Khalaf, K. and Parnianpour, M. (2015) The effects of movement speed on kinematic variability and dynamic stability of the trunk in healthy individuals and low back pain patients. Clinical Biomechanics, 30 (7). pp. 682-688.

Mohsenzadegan, M. and Madjd, Z. and Asgari, M. and Abolhasani, M. and Shekarabi, M. and Taeb, J. and Shariftabrizi, A. (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: A tissue microarray analysis. Cancer Immunology, Immunotherapy, 62 (10). pp. 1609-1618.

Malakoutian, T. and Asgari, M. and Houshmand, M. and Mohammadi, R. and Aryani, O. and Pargoo, E.M. and Ghods, A.J. (2011) Recurrence of primary hyperoxaluria after kidney transplantation. Iranian Journal of Kidney Diseases, 5 (6). pp. 429-433.

Keymoosi, H. and Gheytanchi, E. and Asgari, M. and Shariftabrizi, A. and Madjd, Z. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pacific Journal of Cancer Prevention, 15 (5). pp. 2013-2020. ISSN 1513-7368

This list was generated on Sun Dec 15 01:21:02 2019 +0330.